We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Attacked Over Lipitor Licensing Pact

Law360 (November 8, 2006, 12:00 AM EST) -- Astellas Pharma Inc. has hit pharmaceutical giant Pfizer Inc. with a lawsuit, hoping to assert its purported right to market the blockbuster cholesterol drug Lipitor in Japan.

On Tuesday, Astellas filed suit at the Tokyo District Court, asking the court to weigh in on a dispute over when the duo’s marketing agreement involving Lipitor expires.

The Japanese company currently sells Lipitor under a previously established licensing agreement with Pfizer.

The contract is supposed to be valid until the expiration of the drug's patents, which cover Lipitor's...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.